Article Information
vol. 30 no. 159
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 20, 2020
- Accepted October 7, 2020
- Published online January 13, 2021.
Copyright & Usage
Copyright ©ERS 2021. This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- 1Dept of Thoracic Surgery, Thoraxklinik, University Hospital Heidelberg, Heidelberg, Germany
- 2Translational Lung Research Center (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany
- Hauke Winter, Dept of Thoracic Surgery, Thoraxklinik, Heidelberg University Hospital, Roentgenstraße 1, 69126 Heidelberg, Germany. E-mail: hauke.winter{at}med.uni-heidelberg.de
Article usage
Altmetrics
Vol 30 Issue 159
Table of Contents
How to handle oligometastatic disease in nonsmall cell lung cancer
Jump To
- Article
- Abstract
- Abstract
- Introduction
- Definition of the oligmetastatic situation and prognostic implications
- Ablative techniques in the treatment of oligometastases
- Lung oligometastases
- Brain metastases
- Adrenal metastases
- Bone metastases
- Other extrathoracic locations
- The role of systemic treatment of oligometastatic disease
- Current patient selection and prognostic factors
- Ongoing clinical trials
- Conclusion and future directions
- Footnotes
- References
- Figures & Data
- Info & Metrics